Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record now shows Active, not recruiting and an updated title reflecting Relapse/Refractory AML. It also adds new sections including IPDSharing, Contacts/Locations, Study Design, Conditions, Study Description, Oversight, Sponsor/Collaborators, and Recruitment Status.
    Difference
    2%
    Check dated 2026-01-06T03:21:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a new revision entry (Revision: v3.3.3) to the study's Record History. Removed the HHS Vulnerability Disclosure item and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-22T23:56:21.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.2) was added. The previous revision (v3.3.1) was removed.
    Difference
    0.1%
    Check dated 2025-12-01T15:52:58.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the history and the v3.2.0 revision was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:49.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The government funding status notice/banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:25:45.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A new version entry appears in the record history, while the main study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:06:58.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.